Galleri is a multi-cancer early detection test that looks for a signal shared across more than 50 types of cancer through a simple blood draw.
It is intended to complement U.S. guideline-recommended cancer screenings
and is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older.
The Galleri test can detect more than 50 types of cancer before symptoms appear
, particularly those that are typically difficult to identify early or for which there are no NHS screening programmes.
Galleri is a multi-cancer early detection (MCED) test that looks for a signal shared across more than 50 types of cancer through a simple blood draw. Many of these cancers are not commonly screened for today and otherwise may go unnoticed before symptoms appear.
Galleri® | Multi-Cancer Early Detection | Homepage
The Galleri test is a game-changing technique that can detect more than 50 kinds of cancer in one simple blood test. It uses Next-Generation DNA Sequencing and machine learning to look at various patterns in the DNA code and figure out if a cancer signal is present and from where the cancer likely started. If a cancer signal is detected, the cancer is likely coming from the individual's liver, kidneys, or pancreatics, and if it is detected, the doctor may recommend further tests to determine the cause of the cancer.
The Galleri Test: A New Blood Test for Cancer Screening - Cleveland Clinic
GRAIL is a company that develops a multi-cancer early detection test, Galleri, which can detect multiple types of cancers through a single blood draw. The Galleri test is intended to be complementary to, and not a replacement of, U.S. guideline-recommended cancer screening, and GRAIL is also developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older, and should be used in addition to routine cancer screening tests recommended by a healthcare provider.
Our Products - GRAIL
Mayo Clinic today recognized a multi-cancer early cancer detection (MCED) test called Galleri™ that can detect more than 50 types of cancers through a simple blood draw. The Galleri test is intended to complement U.S. guideline-recommended cancer screenings
Early Cancer Detection Test Studied at Mayo Clinic
It's hoped the Galleri test can detect more than 50 types of the disease before symptoms appear.
It's a simple blood test that looks for the earliest signs of cancer, particularly those that are typically difficult to identify early or for which there are no NHS screening programmes - such as lung, pancreas or stomach cancers.
Galleri cancer test: What is it and who can get it? - BBC News
A trial to transform early cancer detection Around 140,000 people aged 50 to 77 have volunteered to take part in the trial after receiving an invitation letter from the NHS.…
NHS-Galleri Trial | Detecting cancer early